MetLife Inc. Files 98th Amendment to Schedule 13D

Ticker: MET-PF · Form: SC 13D/A · Filed: Aug 1, 2024 · CIK: 1099219

Metlife Inc SC 13D/A Filing Summary
FieldDetail
CompanyMetlife Inc (MET-PF)
Form TypeSC 13D/A
Filed DateAug 1, 2024
Risk Levellow
Pages6
Reading Time7 min
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, 13d-amendment, regulatory

Related Tickers: MET

TL;DR

MetLife filed its 98th 13D amendment on Aug 1. Keep an eye on this.

AI Summary

MetLife Inc. filed an amendment (Amendment No. 98) to its Schedule 13D on August 1, 2024. The filing concerns MetLife's Common Stock. Monica M. Curtis, Executive Vice President and Chief Legal Officer, is listed as the authorized person to receive notices. The filing is an update under the Securities Exchange Act of 1934.

Why It Matters

This filing indicates ongoing reporting requirements and potential changes in the ownership or control of MetLife Inc., requiring investor attention.

Risk Assessment

Risk Level: low — This is a routine amendment to a Schedule 13D filing, not indicating a specific new event or significant change.

Key Numbers

  • 98 — Amendment Number (Indicates this is the 98th update to the Schedule 13D filing.)

Key Players & Entities

  • METLIFE INC (company) — Subject Company
  • Monica M. Curtis (person) — Authorized person to receive notices
  • 200 Park Avenue New York, NY 10166-0188 (address) — Business and Mail Address for MetLife Inc.
  • August 1, 2024 (date) — Date of Event Requiring Filing

FAQ

What is the purpose of this Schedule 13D/A filing?

This filing is an amendment (Amendment No. 98) to a previously filed Schedule 13D under the Securities Exchange Act of 1934, indicating an update to information regarding beneficial ownership or control of MetLife Inc.

Who is authorized to receive notices for this filing?

Monica M. Curtis, Executive Vice President and Chief Legal Officer of MetLife, Inc., is authorized to receive notices and communications.

What is the CUSIP number for MetLife Inc.'s Common Stock?

The CUSIP number for MetLife Inc.'s Common Stock, par value $.01 per share, is 59156R108.

When was this amendment filed?

This amendment was filed on August 1, 2024.

What is the business address of MetLife Inc.?

The business address of MetLife Inc. is 200 Park Avenue, New York, NY 10166-0188.

Filing Stats: 1,677 words · 7 min read · ~6 pages · Grade level 10.7 · Accepted 2024-08-01 16:38:49

Filing Documents

PURPOSE OF TRANSACTION

ITEM 4. PURPOSE OF TRANSACTION. The Board of Directors (the Board) is reporting beneficial ownership of 113,929,100 shares of Common Stock (the Shares) held by the MetLife Policyholder Trust (the Trust) under the Plan of Reorganization, dated September 28, 1999, as amended (the Plan), of Metropolitan Life Insurance Company (MetLife). On April 7, 2000, 494,466,664 Shares were issued to the Trust pursuant to Section 5.2(d) of the Plan, a copy of which is attached as an exhibit to this statement. No consideration has been separately provided therefor by any member of the Board, except for Shares allocated to such member pursuant to the Plan. Since April 7, 2000, transactions by Beneficiaries (i) under the Purchase and Sale Program provided for by the Trust Agreement (as defined below), (ii) pursuant to the Issuers split-off of Reinsurance Group of America, Incorporated, in September 2008, and (iii) to withdraw Shares from the Trust, as well as escheatment of unclaimed Shares, have resulted in a decrease in the number of Shares held by the Trust from 494,466,664 to 113,929,100 (as adjusted to reflect refinements in the calculation of the number of Shares issued to the Trust under the Plan). Under the Plan and the MetLife Policyholder Trust Agreement, dated as of November 3, 1999 (as amended, the Trust Agreement), by and among MetLife, the Issuer, Wilmington Trust Company (the Trustee) and ChaseMellon Shareholder Services, L.L.C., as custodian (now known as Computershare Inc., the Custodian), a copy of which is attached as an exhibit to this statement, certain eligible policyholders of MetLife (Trust Eligible Policyholders) have been allocated a number of interests in the Trust (Trust Interests) equal to the number of shares of Common Stock allocated to the Trust Eligible Policyholders in accordance with the Plan. The assets of the Trust principally are the Shares issued to the Trust for the benefit of the Trust Eligible Policyholders and permitted transferees (col

INTEREST IN SECURITIES OF THE ISSUER

ITEM 5. INTEREST IN SECURITIES OF THE ISSUER. (a) As an entity, the Board of the Issuer beneficially owns 113,929,100 shares, or 16.3% of the Issuers outstanding Common Stock. The Board of the Issuer is deemed to beneficially own the shares of Common Stock held by the Trust because the Board will direct the voting of these shares on certain matters submitted to a vote of stockholders. See Item 4. (b) As an entity, the Board of the Issuer has shared voting power with respect to 113,929,100 shares of Common Stock. (c) There were no transactions in the class of securities reported on that were effected by the Reporting Persons since April 30, 2024 other than transactions described in Item 4 which resulted in a decrease in the number of shares of Common Stock held by the Trust from 115,248,427 to 113,929,100. (d) The Beneficiaries of the Trust have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Shares allocated to them under the Plan and the Trust Agreement. See Item 4.

MATERIAL

ITEM 7. MATERIAL TO BE FILED AS EXHIBITS. Exhibit 99.1 Joint Filing Agreement under Rule 13d-1(k)(1) SCHEDULE 13D CUSIP No. 59156R108 Page 6 of 9 Pages

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, we certify that the information set forth in this statement is true, complete and correct. Dated: August 1, 2024 * Cheryl W. Grisé * Carlos M. Gutierrez * Carla A. Harris * Laura J. Hay * David L. Herzog * R. Glenn Hubbard * Jeh C. Johnson * Edward J. Kelly, III * William E. Kennard * Michel A. Khalaf * Diana L. McKenzie * Denise M. Morrison * Mark A. Weinberger SCHEDULE 13D CUSIP No. 59156R108 Page 7 of 9 Pages * By /s/ John A. Hall John A. Hall Attorney-in-fact

View Full Filing

View this SC 13D/A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.